ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) entered into an agreement with Bellicum Pharmaceuticals, Inc. to restructure and amend an existing license agreement between the companies for ARIAD’s cell-signaling technology. Under the terms of the agreement, ARIAD received $15 million upon execution of the agreement and was entitled to receive two payments of $20 million and $15 million by specified dates in the future in exchange for granting … Continue reading Top Stocks: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Pretium Resources Inc. (NYSE:PVG), Nexstar Broadcasting Group, Inc. (NASDAQ:NXST), Xilinx Inc. (NASDAQ:XLNX), Marvell Technology Group (NASDAQ:MRVL)